- Home
- MDWD vs PERF Comparison
MDWD vs PERF Comparison
Compare MDWD & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDWD
- PERF
- Stock Information
- Founded
- MDWD 2000
- PERF 2015
- Country
- MDWD Israel
- PERF Taiwan
- Employees
- MDWD N/A
- PERF N/A
- Industry
- MDWD Medicinal Chemicals and Botanical Products
- PERF Computer Software: Prepackaged Software
- Sector
- MDWD Health Care
- PERF Technology
- Exchange
- MDWD Nasdaq
- PERF Nasdaq
- Market Cap
- MDWD 208.2M
- PERF 191.5M
- IPO Year
- MDWD 2014
- PERF N/A
- Fundamental
- Price
- MDWD $17.14
- PERF $2.00
- Analyst Decision
- MDWD Strong Buy
- PERF Buy
- Analyst Count
- MDWD 2
- PERF 1
- Target Price
- MDWD $35.00
- PERF $5.00
- AVG Volume (30 Days)
- MDWD 154.9K
- PERF 145.1K
- Earning Date
- MDWD 08-14-2025
- PERF 10-28-2025
- Dividend Yield
- MDWD N/A
- PERF N/A
- EPS Growth
- MDWD N/A
- PERF 4.30
- EPS
- MDWD N/A
- PERF 0.06
- Revenue
- MDWD $19,858,000.00
- PERF $64,369,000.00
- Revenue This Year
- MDWD $20.37
- PERF $15.84
- Revenue Next Year
- MDWD $25.91
- PERF $14.54
- P/E Ratio
- MDWD N/A
- PERF $33.23
- Revenue Growth
- MDWD N/A
- PERF 13.19
- 52 Week Low
- MDWD $14.14
- PERF $1.51
- 52 Week High
- MDWD $22.51
- PERF $3.44
- Technical
- Relative Strength Index (RSI)
- MDWD 45.84
- PERF 49.90
- Support Level
- MDWD $16.08
- PERF $1.88
- Resistance Level
- MDWD $20.30
- PERF $1.97
- Average True Range (ATR)
- MDWD 0.93
- PERF 0.08
- MACD
- MDWD 0.20
- PERF 0.01
- Stochastic Oscillator
- MDWD 25.12
- PERF 46.77
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.